Raia Drogasil S.A.
RADLY
$3.56
$0.2597.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.16B | 7.10B | 7.22B | 7.30B | 7.28B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.16B | 7.10B | 7.22B | 7.30B | 7.28B |
| Cost of Revenue | 5.05B | 5.00B | 5.08B | 5.12B | 5.11B |
| Gross Profit | 2.10B | 2.10B | 2.15B | 2.18B | 2.17B |
| SG&A Expenses | 1.69B | 1.69B | 1.71B | 1.73B | 1.74B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.46M | 5.75M | 12.39M | -8.85M | -22.89M |
| Total Operating Expenses | 6.75B | 6.70B | 6.80B | 6.85B | 6.83B |
| Operating Income | 408.62M | 407.80M | 426.53M | 454.10M | 453.15M |
| Income Before Tax | 232.03M | 241.26M | 263.59M | 275.52M | 257.89M |
| Income Tax Expenses | 15.54M | 29.28M | 40.77M | 56.07M | 44.62M |
| Earnings from Continuing Operations | 216.49 | 211.98 | 222.82 | 219.45 | 213.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.49M | -1.30M | -2.22M | -5.72M | -5.89M |
| Net Income | 214.00M | 210.68M | 220.60M | 213.73M | 207.37M |
| EBIT | 408.62M | 407.80M | 426.53M | 454.10M | 453.15M |
| EBITDA | 539.81M | 536.38M | 557.48M | 587.34M | 588.14M |
| EPS Basic | 0.13 | 0.11 | 0.12 | 0.11 | 0.11 |
| Normalized Basic EPS | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
| EPS Diluted | 0.13 | 0.11 | 0.12 | 0.11 | 0.11 |
| Normalized Diluted EPS | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
| Average Basic Shares Outstanding | 6.59B | 7.81B | 7.82B | 7.88B | 7.92B |
| Average Diluted Shares Outstanding | 6.62B | 7.83B | 7.84B | 7.91B | 7.94B |
| Dividend Per Share | 0.03 | 0.03 | 0.02 | 0.07 | 0.04 |
| Payout Ratio | 44.38% | 40.88% | 39.05% | 44.02% | 45.30% |